Wunderlich Capital Managemnt’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$1.96M Buy
3,539
+18
+0.5% +$10.3K 0.87% 49
2024
Q1
$2.05M Sell
3,521
-206
-6% -$116K 0.92% 48
2023
Q4
$1.98M Sell
3,727
-456
-11% -$221K 0.89% 50
2023
Q3
$2.12M Sell
4,183
-8
-0.2% -$4.26K 1.04% 44
2023
Q2
$2.19M Buy
4,191
+44
+1% +$23.7K 1.07% 43
2023
Q1
$2.39M Buy
4,147
+59
+1% +$33.3K 1.24% 41
2022
Q4
$2.25M Sell
4,088
-18
-0.4% -$9.54K 1.25% 39
2022
Q3
$2.08M Buy
4,106
+95
+2% +$53.2K 1.33% 32
2022
Q2
$2.18M Buy
4,011
+27
+0.7% +$14.9K 1.27% 37
2022
Q1
$2.35M Hold
3,984
1.11% 46
2021
Q4
$2.66M Buy
3,984
+192
+5% +$120K 1.18% 45
2021
Q3
$2.17M Sell
3,792
-58
-2% -$31.8K 1.04% 51
2021
Q2
$1.94M Buy
3,850
+81
+2% +$38.2K 0.98% 55
2021
Q1
$1.72M Buy
+3,769
New +$1.8M 0.94% 57

Other funds holding TMO

Wunderlich Capital Managemnt's TMO Position: Q2 2024 in Review

Wunderlich Capital Managemnt increased its Thermo Fisher Scientific (TMO) stake by 0.51% in Q2 2024, buying an estimated $10.3K and bringing the position to 3,539 shares worth $1.96M. The position accounts for 0.87% of the portfolio, ranked #49.

Wunderlich Capital Managemnt first reported a position in TMO in Q1 2021 and has held it in 14 quarters since. The position peaked at $2.66M in Q4 2021. 2,543 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Wunderlich Capital Managemnt held 3,539 shares of Thermo Fisher Scientific worth $1.96M as of Q2 2024.
  • Wunderlich Capital Managemnt bought 18 Thermo Fisher Scientific shares in Q2 2024, an estimated $10.3K.
  • Thermo Fisher Scientific made up 0.87% of Wunderlich Capital Managemnt's portfolio in Q2 2024, its #49 holding.
  • Wunderlich Capital Managemnt first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 14 quarters since.
  • Wunderlich Capital Managemnt's Thermo Fisher Scientific position peaked at $2.66M in Q4 2021.
  • 2,543 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Wunderlich Capital Managemnt's 13F filing for Q2 2024, filed 14 Aug 2024.